SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-23-095738
Filing Date
2023-12-14
Accepted
2023-12-14 16:30:05
Documents
7
Period of Report
2023-12-14

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea189804-pre14a_180life.htm PRE 14A 515975
2 GRAPHIC img_001.jpg GRAPHIC 5180
3 GRAPHIC img_002.jpg GRAPHIC 1991
4 GRAPHIC img_003.jpg GRAPHIC 1561
5 GRAPHIC img_004.jpg GRAPHIC 1405
6 GRAPHIC img_005.jpg GRAPHIC 2147
7 GRAPHIC img_006.jpg GRAPHIC 10080
  Complete submission text file 0001213900-23-095738.txt   548725
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38105 | Film No.: 231487418
SIC: 2834 Pharmaceutical Preparations